ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 408,64
-0,30%
Dow Jones
42 297,12
0,86%
DAX
20 132,85
-0,44%
Brent Oil
79,885
-0,49%
Bitcoin
95 152,41
0,68%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ

  6. Shuttle Pharmaceuticals Holdings Inc (SHPH) Cours

Shuttle Pharmaceuticals Holdings Inc

Shuttle Pharmaceuticals Holdings Inc (SHPH)

NASDAQ
0,8999
0,0299
(3,44%)
Fermé 14 Janvier 10:00PM
Retardé de 15 minutes
0,87
-0,0299
(-3,32%)
Après les heures de négociation: 1:48AM
Retardé de 15 minutes

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
0,87
Prix Achat
0,87
Prix Vente
0,91
Volume échangé
90 700
0,87 Fourchette du Jour 0,9244
0,58 Plage de 52 semaines 4,9464
Cap du marché
3,188M
Clôture Veille
0,87
Ouverture
0,8703
Dernière Transaction
450
@
0.87
(formt)
Dernière heure de transaction
Volume financier
US$ 81 678
VWAP
0,900525
Volume moyen (3 m)
1 232 922
Actions en circulation
3 664 919
Rendement du Dividende
-
Ratio Cours sur Bénéfices
-0,49
Bénéfice par action (BPA)
-1,8
Chiffre d'affairess
-
Bénéfice net
-6,59M

À propos de Shuttle Pharmaceuticals Holdings Inc

Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surg... Shuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and immunotherapy. Show more

Secteur
Pharmaceutical Preparations
Industrie
Pharmaceutical Preparations
Siège social
Wilmington, Delaware, USA
Fondé
-
Shuttle Pharmaceuticals Holdings Inc est coté dans le secteur Pharmaceutical Preparations de la NASDAQ avec le ticker SHPH. Le dernier cours de clôture d'Shuttle Pharmaceuticals était de US$0,87. Au cours de la dernière année, les actions de Shuttle Pharmaceuticals ont été négociées dans une fourchette de prix de US$ 0,58 à US$ 4,9464.

Shuttle Pharmaceuticals compte actuellement 3 664 919 actions en circulation. La capitalisation boursière d'Shuttle Pharmaceuticals est de US$3,19 million. Shuttle Pharmaceuticals a un ratio cours/bénéfice (ratio PE) de -0.49.

SHPH Dernières nouvelles

Plus de nouvelles

Form 8-K - Current report

07 Janvier 2025
Edgar (US Regulatory)

Shuttle Pharma to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

GAITHERSBURG, Md., Jan. 07, 2025 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...

07 Janvier 2025
GlobeNewswire Inc.

Form 8-K - Current report

19 Décembre 2024
Edgar (US Regulatory)

Shuttle Pharma Enters into Sponsored Research Agreement with the University of California, San Francisco to Advance PSMA Development Program

GAITHERSBURG, Md., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...

19 Décembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

26 Novembre 2024
Edgar (US Regulatory)

Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma as UVA Cancer Center Doses Its First Patient

GAITHERSBURG, Md., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma”), a discovery and development stage specialty pharmaceutical company...

26 Novembre 2024
GlobeNewswire Inc.

Form 8-K - Current report

13 Novembre 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

13 Novembre 2024
Edgar (US Regulatory)

Shuttle Pharma Provides Third Quarter 2024 Corporate Update

GAITHERSBURG, Md., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage specialty...

13 Novembre 2024
GlobeNewswire Inc.

Form EFFECT - Notice of Effectiveness

30 Octobre 2024
Edgar (US Regulatory)
PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.05-5.43478260870.920.94990.821899070.87590868CS
40.185327.06294727620.68470.94990.581331630.73942411CS
12-0.38-30.41.252.250.5812329221.68270268CS
26-2.5236-74.36350777933.39364.2960.589465772.06485185CS
52-2.8812-76.80742162513.75124.94640.585233072.19378936CS
156-191.53-99.5478170478192.41010.080.5880404345.51883591CS
260-191.53-99.5478170478192.41010.080.5880404345.51883591CS

SHPH - Frequently Asked Questions (FAQ)

What is the current Shuttle Pharmaceuticals share price?
The current share price of Shuttle Pharmaceuticals is US$ 0,87
How many Shuttle Pharmaceuticals shares are in issue?
Shuttle Pharmaceuticals has 3 664 919 shares in issue
What is the market cap of Shuttle Pharmaceuticals?
The market capitalisation of Shuttle Pharmaceuticals is USD 3,19M
What is the 1 year trading range for Shuttle Pharmaceuticals share price?
Shuttle Pharmaceuticals has traded in the range of US$ 0,58 to US$ 4,9464 during the past year
What is the PE ratio of Shuttle Pharmaceuticals?
The price to earnings ratio of Shuttle Pharmaceuticals is -0,49
What is the reporting currency for Shuttle Pharmaceuticals?
Shuttle Pharmaceuticals reports financial results in USD
What is the latest annual profit for Shuttle Pharmaceuticals?
The latest annual profit of Shuttle Pharmaceuticals is USD -6,59M
What is the registered address of Shuttle Pharmaceuticals?
The registered address for Shuttle Pharmaceuticals is 1013 CENTRE ROAD SUITE 403-B, WILMINGTON, DELAWARE, 19805
Which industry sector does Shuttle Pharmaceuticals operate in?
Shuttle Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

Moteurs

Voir tout
  • Volume
  • % Gagnants
  • % Perdants
SymbolePrixVol.
PHIOPhio Pharmaceuticals Corporation
US$ 6,50
(284,62%)
281,98M
SLRXSalarius Pharmaceuticals Inc
US$ 3,65
(133,23%)
120,26M
VRMEVerifyMe Inc
US$ 4,1575
(63,04%)
57,6M
ATPCAgape ATP Corporation
US$ 1,9645
(55,91%)
84,16M
AVGRAvinger Inc
US$ 0,8248
(46,47%)
9,78M
EHGOEshallgo Inc
US$ 1,2408
(-62,06%)
6,74M
CMTLComtech Telecommunications Corporation
US$ 2,3491
(-43,12%)
4,37M
SVMHSRIVARU Holding Ltd
US$ 0,0352
(-43,04%)
184,27M
LAESSEALSQ Corporation
US$ 3,35
(-41,54%)
89,92M
NMHINatures Miracle Holding Inc
US$ 1,12
(-38,80%)
735,08k
GCTKGlucoTrack Inc
US$ 0,1493
(27,61%)
685,02M
PHIOPhio Pharmaceuticals Corporation
US$ 6,50
(284,62%)
281,98M
BHATBlue Hat Interactive Entertainment Technology
US$ 0,0627
(-28,83%)
232,25M
NVDANVIDIA Corporation
US$ 133,23
(-1,97%)
204,68M
RGTIRigetti Computing Inc
US$ 6,0344
(-32,43%)
192,21M

Forums

Afficher les forums
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

NASDAQ
SHPH
Shuttle Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2025 ADVFN PLC - Tous droits réservés